An exploratory assessment of the gaps for health innovation in Brazil:challenges and a proposed research agenda Outros Idiomas

BoriniAbstractPolicies and health actions generate benefits that extrapolate the specificity of its purpose of providing welfare for the population, given itsrecognized impact in generating technological innovations, employment and income. However, such progress levels are unevenly distributed incountries, so that certain diseases and allocative and ethical questions associated with the development of new mechanisms for diagnosis, oftreatment and cure did not find satisfactory answers yet. In Brazil, such a scenario has not been shown different, demanding a wider discussionencompassing the country’s economic and social conditions. Contrasting the analytical and empirical results observed in policies and actions towardthe Health Economic-Industrial Complex (CEIS) to establish the barriers as well as structural and economic opportunities for the promotion ofhealth innovations in Brazil, this work raises a number of critical considerations in view of identifying and systematizing gaps in health innovationin the country, thereby proposing a positive comprehensive research agenda on the topic.
Citação ABNT:
ALVESA, A. S.; BOTELHO, A. J. J.; MENDES, L. An exploratory assessment of the gaps for health innovation in Brazil:challenges and a proposed research agenda. Innovation and Management Review, v. 14, n. 2, p. 98-108, 2017.
Citação APA:
Alvesa, A. S., Botelho, A. J. J., & Mendes, L. (2017). An exploratory assessment of the gaps for health innovation in Brazil:challenges and a proposed research agenda. Innovation and Management Review, 14(2), 98-108.
Link Permanente:
Tipo de documento:
Aguinis, H.; Glavas, A. (2012). What we know and don’t know about corporate social responsibility: A review agenda. Journal of Management, 932-968.

Alves, A. S.; Pimenta-Bueno, J. A. (2014). An exploratory assessment of public financing of university-industry cooperation in Brazil. Production, 24(4), 898-910.

Alves, A. S.; Quelhas, O. L.; da Silva, M. H.; Lameira, V. J. (2015). On the role of university in the promotion of innovation: Exploratory evidences from a university-industry cooperation experience in Brazil. International Journal of Innovation and Learning, 17(1), 1-18.

Bahia, L.; Costa, L. S.; Gadelha, C. A.; Vargas, M. A. (2015). Compras governamentais: as mãos visíveis do Estado para a inovação. In Saúde, Desenvolvimento e Inovação. pp. 349. Rio de Janeiro: CEPESC-IMS/UERJ-FIOCRUZ.

Battelle. (2013). 2014 Global R&D funding forecast. Battelle: Brussels.

Bloom, G.; Wolcott, S. (2013). Building institutions for health and health sys-tems in contexts of rapid change. Social Science & Medicine, 96, 216-222.

Botelho, J. A.; Almeida, M. (2010). Overcoming institutional shortcomings for academic spin-off policies in Brazil. International Journal of Tecnology Management and Sustainable Development, 9, 175-193.

Brazilian Association of Pharmaceutical chemicals Industry and Pharmaceutical Supplies. (2014). Índex 2014: insumos farmacêuticos e seus produtores [Index 2014: pharmaceutical ingredients and their producers]. Rio de Janeiro: ABIQUIFI.

Brazilian Association of Venture Capital and Private Equity. (2016). Con-solidação de Dados da Indústria de Private Equity e Venture Capital no Brasil (2011.2012.2013.2014.2015). Rio de Janeiro: ABDI. Accesed on 14 October 2016, available at

Cassiolato, J. E.; Soares, M. C. (2015). Saúde e Inovação: territorialização do complexo econômico-industrial da saúde. In L. S. Costa, L. Bahia, & C. A. Gadelha (Eds.), Saúde, Desenvolvimento e Inovação. (p. 349). Rio de Janeiro: CEPESC-IMS/UERJ-FIOCRUZ.

Consoli, D.; Mina, A. (2009). An evolutionary perspective on health innovation systems. Journal of Evolutionary Economics, 19, 297-319.

Davis, C.; Abraham, J. (2013). Unhealthy pharmaceutical regulation: Innovation, politics and promissory science. Palgrave Macmillan.

Durand-Zaleski, I.; Chevreul, K.; Jeanblanc, G. (2009). Financing for health in all policies. In I. Kickbusch (Ed.), Policy innovation for health (p. 210). Springer.

Edmondson, A. C.; McManus, S. E. (2007). Methodological fit in management field research. Academy of Management Review, 32(4), 1155-1179.

Federal Planning Bureau. (2013). Machines that go ‘ping’: Medical technology and health expenditures in OECD countries. Brussels: Federal Planning Bureau.

Gadelha, C.; Costa, L. S.; Bahia, L. (2015). Reflexões sobre a saúde na agenda contemporânea do desenvolvimento. In L. S. Costa, L. Bahia, & C. A. Gadelha (Eds.), Saúde, Desenvolvimento e Inovação. (p. 349). Rio de Janeiro: CEPESC-IMS/UERJ-FIOCRUZ.

Gadelha, C. G. (2003). O Complexo Industrial da Sáude e a necessidade de um enfoque dinâmico na economia da saúde. Cienc Saúde Coletiva, 8(2), 521-535.

Gadelha, C. G.; Vargas, M.; Maldonado, J. d.; Barbosa, R. B. (2013). O Complexo Econômico-Industrial da Saúde no Brasil: dinâmica de inovação e implicações para o Sistema Nacional de Inovação em Saúde. Revista Brasileira de Inovação, 12(2), 251-282.

Gelijns, A. C.; Rosenberg, N. (1994). The dynamics of technological change in medicine. Health Affairs, 16(1), 28-46.

Hyewon, A. (2014). Second generation patents in pharmaceutical innovation. Munich: Nomos Publishers.

Industrial Resarch Institute. (2015). 2016 Global R&D Funding Fore-cast. R&D Magazine. Source:

Lange, K.; Muller-Seitz, G.; Windeler, A. (2013). Financing innovations in uncertain networks: Filling in roadmap gaps in the semiconductor industry. Research Policy, (42), 647-661.

Lehoux, P.; Daudelin, G.; Williams-Jones, B.; Denis, J. L.; Longo, C. (2014). How do business model and health technology design influence each other?Insights from a longitudinal case study of three academic spin-offs. Research Policy, (43), 1025-1038.

Machado, D. D.; Barzotto, L. d. (2014). Ambiente de inovação em instituição hospitalar. Innovation & Management Review, 9(1), 51-80.

Marques, M. B. (1999). Gestão, planejamento e avaliação de políticas de ciência e tecnologia: hora de rever? Ciência & Saúde Coletiva, 4(2), 383-392.

Mazzucato, M.; Dosi, G. (Eds.). (2006). Knowledge accumlation and industry evolution: The case of pharma-biotech. Cambridge: Cambridge University Press.

Metrick, A.; Yasuda, A. (2011). Venture capital and the finance of innovation. 2a ed. New Jersey: Wiley.

Ministry of Health. (2016). Plano Nacional da Saúde 2016-2019. Brasília-DF: Ministerio da Sáude (MS).

Ministry of Science, Technology and Innovation. (2015). Estratégia Nacional de Ciência, Tecnologia e Inovação 2016-2019. Brasília-DF: Ministério da Ciência, Tecnologia e Inovação (MCTI).

Organization for Economic Cooperation and Development. (2010). Biomedicine and Health Innovation-SYNTHESIS REPORT. Paris.

Organization for Economic Cooperation and Development. (2013). Health inno-vation. In OECD, OECD, science, technology and industry scoreboard 2013: Innovation for growth. Paris: OECD Publishing.

Orsenigo, L.; Dosi, G.; Mazzucato, M. (2006). The dynamics of knowledge accumulation, regulation, and appropriability in the pharma-biotech sector: Policy issues. In M. Mazzucato, & G. Dosi (Eds.), Knowledge accumlation and industry evolution: The case of pharma-biotech. pp. 379-402. Cambridge: Cambrigde Univeristy Press.

Paranhos, J.; Hasenclever, L. (2011). The relevance of industry-university rela-tionship for the Brazilian pharmaceutical systems of innovation. In A. Pyka, & M. G. Fonseca (Eds.), Catching up, spillovers and innovation networks in a schumpeterian perspective. Berlin: Springer-Verlag.

Parasuraman, A.; Grewal, D. (2000). The impact of technology on the quality-value-loyalty chain: A research agenda. Academy of Marketing Science Journal, 168-174.

Pinto, K. E.; Feldmann, P. R. (2016). Why Brazil doesn’t innovate: A comparison among nations. Innovation & Management Review, 13(1), 63-82.

Plaza, C. M.; Santos, N. d. (2011). Patentes de segundo uso farmacêutico versus inovação: questões polêmicas. In P. A. del Nero (Ed.), Propriedade intelectual e transferência de tecnologia. Belo Horizonte: Fórum.

Probert, J.; Connel, D.; Mina, A. (2013). R&D service firms: The hidden engine of the high-tech economy. Research Policy, 42, 1274-1285.

Stossel, T. P. (2015). Pharmaphobia: How the conflict of interest myth under-mines American medical innovation. Rowman & Littlefield.

Suzigan, W.; Albuquerque, E. M.; Cario, S. A. (2011). Nd. In: W. Suzigan, E. M. Albuquerque, & S. A. Cario (Eds.), Em busca da inovação: interação universidade-empresa no Brasil. Belo Horizonte: Autêntica Editora.

Viana, A. L.; Elias, P. E. (2007). Saúde e desenvolvimento. Ciência & Saúde Coletiva, 12(Supl.), 1765-1777.

Yin, R. K. (2003). Case study research: Design and methods. 3 ed. London: Sage Publications.